MicroRNAs as Biomarkers and Therapeutic Targets in Treatment-Resistant Depression: Unveiling Diagnostic and Treatment Pathways
This review highlights miRNAs as promising diagnostic and therapeutic tools in TRD. Continued advancements in delivery systems and validation of biomarker panels may pave the way for their clinical implementation in personalized psychiatry.
Authors
- Almuthanna K. Alkaraki (ORCID: https://orcid.org/0000-0003-0983-1348)
- Abdelrahim M. Alqudah (ORCID: https://orcid.org/0000-0003-3721-8225)
- Alaa A. A. Aljabali (ORCID: https://orcid.org/0000-0002-9519-6338)
- Walhan Alshaer (ORCID: https://orcid.org/0000-0003-2946-7328)
- Vijay Kumar Mishra (ORCID: https://orcid.org/0000-0001-6542-2464)
- Yachana Mishra (ORCID: https://orcid.org/0000-0002-3467-0518)
- Esam Y. Qnais (ORCID: https://orcid.org/0000-0002-6203-4527)
- Mohamed El‐Tanani (ORCID: https://orcid.org/0000-0002-4735-5445)
- Omar Gammoh (ORCID: https://orcid.org/0000-0001-8801-2652)
Institutions
- Lovely Professional University (IN)
- University of Jordan (JO)
- Hashemite University (JO)
- Yarmouk University (JO)
- Ras al-Khaimah Medical and Health Sciences University (AE)
Publication Details
- Journal
- Current Reviews in Clinical and Experimental Pharmacology
- Published
- 2025-09-01
- DOI
- https://doi.org/10.2174/0127724328381443250825092900
- Primary Topic
- MicroRNA in disease regulation
- Type
- article
- Field-Weighted Citation Impact
- 0.00